| My Account | Subscribe | Contact Us | Help |
Even drops in the bucket make a difference
It has been 22 years since Air Canada pilot Steve Steele was grounded with type 1
A traveling couple tries to stick to low carbs
Here’s something to make you sit up and take notice (maybe 100 times a night): 23 percent of type 2s have obstructive sleep apnea.
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Related Medications Threads on Diabetes Health Forums
Love Thy Pharmacist: Prescription Drugs in Mexico Might Not Be What They Seem
If your summer travels take you south of the border into Mexico, pharmacists say you should avoid the temptation of saving a few dollars by purchasing your medications at farmacias, which sell versions of American prescription drugs made in Mexico.
4 comments - Aug 5, 2008 -
Diabetes Drugs Are Now the Top Driver In Drug Spending Growth, Says Report
Diabetes treatments are now the leading driver of prescription drug spending growth, displacing lipid-lowering drugs, which tumbled in price after a reign of 10 years in the top position. Generic drugs are cutting the cost of treating high cholesterol.
2 comments - Jun 12, 2008 -
Legal and Illegal Drugs: What Every Person With Diabetes Should Know Before They Party
Perhaps more than anyone, people with diabetes know that the motto “Just say no” often doesn’t work.
20 comments - Mar 13, 2008 -
Bayer Diabetes Care has recalled 230,000 bottles of Contour TS test strips after finding that the strips resulted in blood glucose readings 5 to 17 percent higher than actual levels.
0 comments - Dec 29, 2007 -
An Insulin Prescription for Disaster
In July, I flew from New York City to Phoenix to meet my new book agent. (Trust me, I would not have deliberately sought out 100-degree weather without good reason.) Always thinking ahead, I decided to bring along a fancy new bag specially insulated to keep my insulin cool. Alas, either the bag failed me, or I failed the bag.
3 comments - Nov 25, 2007 -
Los Angeles Times columnist and newly diagnosed type 1 David Lazarus is becoming quite an advocate for people with diabetes.
4 comments - Nov 10, 2007 -
The FDA has spoken: the heart risk warnings on labels of Avandia (rosiglitazone) and Actos (pioglitazone) will now be surrounded by an emphatic black outline known as a black box. Black boxes will also be added to the warnings on Avandaryl (rosiglitazone and glimepiride), Avandamet (rosiglitazone and metformin), and Duetact (pioglitazone and glimepiride).
0 comments - Oct 30, 2007 -
According to a literature review and survey of 132 Canadian pharmacists, 47 percent of pharmacists have encountered an adverse interaction between a natural health product and a drug.
0 comments - Aug 13, 2007 -
Wal-Mart Settles Wrongful Death Suit Due to Insulin Overdose
On December 13, 2005, Keith Scofield visited a Wal-Mart pharmacy in Frederick, Maryland, and ordered over-the-counter Humulin R (u-100). Instead, he was allegedly given Humulin R (u-500), a prescription drug that contains five times the insulin of the requested medication.
2 comments - Aug 7, 2007 -
On July 30, 2007, a Food and Drug Administration (FDA) panel voted 22 to 1 to keep Avandia on the market, right after agreeing by a vote of 20 to 3 that Avandia does increase heart risks. Now the FDA will decide what kind of warning should appear on the Actos and Avandia labels. It has already called for a black box warning, the sternest possible, on Avandia.
0 comments - Aug 1, 2007 -